Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/46790
Campo DC Valoridioma
dc.contributor.authorBoronat, Mauroen_US
dc.contributor.authorGarcía-Cantón, Césaren_US
dc.contributor.authorLópez-Ríos, Lauraen_US
dc.contributor.authorQuevedo, Virginiaen_US
dc.contributor.authorLorenzo, Dionisio L.en_US
dc.contributor.authorBatista, Fátimaen_US
dc.contributor.authorRiaño, Martaen_US
dc.contributor.authorNóvoa, Francisco J.en_US
dc.date.accessioned2018-11-23T08:13:16Z-
dc.date.available2018-11-23T08:13:16Z-
dc.date.issued2014en_US
dc.identifier.issn1479-1641en_US
dc.identifier.urihttp://hdl.handle.net/10553/46790-
dc.description.abstractThis study analyses discordance rates between attainment of therapeutic goals for apolipoprotein B100 (apoB) and both low-density lipoprotein-cholesterol (LDL-C) and non-high-density lipoprotein-cholesterol (non-HDL-C) in a sample of 152 patients with type 2 diabetes and chronic kidney disease from Gran Canaria (Spain), using treatment targets recommended by the American Diabetes Association/American College of Cardiology (ADA/ACC), the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) and by a Spanish population-based study. Among subjects with LDL-C levels at therapeutic goal, apoB was above target in 16.3% (ADA/ACC), 6.5% (ESC/EAS) and 39.1% (population-based criteria), and among subjects with non-HDL-C levels at therapeutic goal, apoB was above target in 10.5% (ADA/ACC), 1.2% (ESC/EAS) and 29.6% (population-based criteria). These findings show that clinical management would be very differently altered depending on the criteria used to set treatment targets for apoB. Cut-off points derived from population data identify a greater number of subjects suitable for a more intensive lipid-lowering therapy.en_US
dc.languageengen_US
dc.relation.ispartofDiabetes and Vascular Disease Researchen_US
dc.sourceDiabetes and Vascular Disease Research [ISSN 1479-1641],v. 11, p. 53-59en_US
dc.subject32 Ciencias médicasen_US
dc.subject3205 Medicina internaen_US
dc.subject.otherApolipoprotein B100,en_US
dc.subject.otherLow-density lipoprotein–cholesterolen_US
dc.subject.otherNon-high-density lipoprotein–cholesterolen_US
dc.subject.otherCardiovascular risken_US
dc.subject.otherLipid goalsen_US
dc.subject.otherType 2 diabetesen_US
dc.titlePotential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney diseaseen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1177/1479164113511834en_US
dc.identifier.scopus84890453908-
dc.identifier.isi000328315700009-
dc.contributor.authorscopusid7003952293-
dc.contributor.authorscopusid6603127359-
dc.contributor.authorscopusid33068166900-
dc.contributor.authorscopusid50561862600-
dc.contributor.authorscopusid55967938300-
dc.contributor.authorscopusid55968288300-
dc.contributor.authorscopusid37067926100-
dc.contributor.authorscopusid12786120600-
dc.description.lastpage59en_US
dc.description.firstpage53en_US
dc.relation.volume11en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid673494-
dc.contributor.daisngid1915819-
dc.contributor.daisngid1964185-
dc.contributor.daisngid5112593-
dc.contributor.daisngid30519221-
dc.contributor.daisngid5867919-
dc.contributor.daisngid5257474-
dc.contributor.daisngid556390-
dc.description.numberofpages7en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Boronat, M-
dc.contributor.wosstandardWOS:Garcia-Canton, C-
dc.contributor.wosstandardWOS:Lopez-Rios, L-
dc.contributor.wosstandardWOS:Quevedo, V-
dc.contributor.wosstandardWOS:Lorenzo, DL-
dc.contributor.wosstandardWOS:Batista, F-
dc.contributor.wosstandardWOS:Riano, M-
dc.contributor.wosstandardWOS:Novoa, FJ-
dc.date.coverdateEnero 2014en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr1,202
dc.description.jcr2,829
dc.description.sjrqQ1
dc.description.jcrqQ2
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0001-8535-8543-
crisitem.author.orcid0000-0002-5988-8222-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameBoronat Cortés, Mauro-
crisitem.author.fullNameGarcía Cantón, César-
crisitem.author.fullNameLorenzo Villegas, Dionisio Lorenzo-
Colección:Artículos
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.